Daniel Cervonka, PA-C, MPAS, CAS
Medical Physician Assistant in New Haven, Connecticut. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 40,527 in Medical Physician Assistant, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daniel Cervonka, PA-C, MPAS, CAS reported a CMS MIPS final score of 97.3/100 - above the 83.1 national average - and filed 263 Medicare Part D claims in 2023.
- 97.3/100
- MIPS score · +14 vs avg
- 263
- Part D claims, 2023
- 80%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Cervonka, PA-C, MPAS, CAS's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
97 Top 15% higher than 85% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Cervonka, PA-C, MPAS, CAS sits
This provider among medical physician assistant peers
Across the 7,339 medical physician assistant providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Cervonka, PA-C, MPAS, CAS writes more Part D claims than 43% of them and scores higher on MIPS quality than 86% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical physician assistant peer from a representative sample of 60; the gold marker is Daniel Cervonka, PA-C, MPAS, CAS. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Daniel Cervonka, PA-C, MPAS, CAS?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Medical Physician Assistant compares to other specialties among Connecticut providers
Medical Physician Assistant ranks #27 among Connecticut's specialties (1.1% of in-state providers)
Each bar is a specialty's share of the Connecticut provider total, by primary NUCC taxonomy. The highlighted bar is Medical Physician Assistant; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Daniel Cervonka, PA-C, MPAS, CAS's 2023 MIPS final score plotted against the Medical Physician Assistant national average
- MIPS Final Score
- 97.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Physician Assistant) - 97.3/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Medical Physician Assistant US NPIs
97.3/100 MIPS final score - 14.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Physician Assistant. Quality dim: 81.7.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Cervonka, PA-C, MPAS, CAS appears in the CMS NPPES registry as a Medical Physician Assistant provider holding PA-C, MPAS, CAS credentials at 20 YORK ST, New Haven, CT, 06510, with a listed phone of (203) 688-9703. NPI 1932125036 was issued on 07/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Cervonka most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 263 prescription claims written by this provider, covering 194 Medicare beneficiaries and totaling roughly $5K in drug spend, split 12% brand-name and 80% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.3/100 for the 2023 performance year (Quality 81.7), compared with the national average of 83.1.
Medical Physician Assistant is a mid-sized specialty nationwide, with 40,527 enrolled providers across 55 states and an average of 1,077 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1932125036 |
|---|---|
| Specialty | Medical Physician Assistant |
| Credentials | PA-C, MPAS, CAS |
| Gender | Male |
| NPI Issued | 07/14/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Daniel Cervonka, PA-C, MPAS, CAS's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 80% generic, on 263 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 267
- Total Day Supply
- 2,727
- Brand vs Generic
- 12% brand / 80% generic
- Brand Drug Cost
- $2K
- Generic Drug Cost
- $3K
- Antibiotic Claims
- 102
Patient Demographics
- Average Patient Age
- 69.5 years
- Avg HCC Risk Score
- 1.10
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 35, 65-74: 97, 75-84: 49, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Cervonka, PA-C, MPAS, CAS prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
25 claims
- Azithromycin
Azithromycin
21 claims
- Cephalexin
Cephalexin
20 claims
- Naloxone Hcl
Naloxone Hcl
18 claims
- Doxycycline Hyclate
Doxycycline Hyclate
17 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
16 claims
- Nitrofurantoin Mon…
Nitrofurantoin Mono-Macro
14 claims
- Fluticasone Propio…
Fluticasone Propionate
13 claims
| Drug | Claims |
|---|---|
| Prednisone | 25 |
| Azithromycin | 21 |
| Cephalexin | 20 |
| Naloxone Hcl | 18 |
| Doxycycline Hyclate | 17 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 14 |
| Fluticasone Propionate | 13 |
| Methylprednisolone | 13 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Physician Assistant Overview
How Daniel Cervonka, PA-C, MPAS, CAS fits within the Medical Physician Assistant landscape nationally.
Daniel Cervonka, PA-C, MPAS, CAS's 263 claims are below the specialty average of 1,077.
Nearby Medical Physician Assistant Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Cervonka.
Compare Medical Physician Assistant nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Physician Assistant peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is Daniel Cervonka, PA-C, MPAS, CAS's specialty? ▼
How much does Daniel Cervonka, PA-C, MPAS, CAS prescribe under Medicare Part D? ▼
What is Daniel Cervonka, PA-C, MPAS, CAS's Medicare quality score? ▼
Where is Daniel Cervonka, PA-C, MPAS, CAS located? ▼
What is Daniel Cervonka, PA-C, MPAS, CAS's NPI number? ▼
Does Daniel Cervonka, PA-C, MPAS, CAS prescribe more brand-name or generic drugs? ▼
How many Medical Physician Assistant providers are there in the US? ▼
What drugs does Daniel Cervonka, PA-C, MPAS, CAS prescribe most often? ▼
Does Daniel Cervonka, PA-C, MPAS, CAS accept Medicare? ▼
How can I verify Daniel Cervonka, PA-C, MPAS, CAS's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology